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Abstract: Many genomic experiments, notably microarray experiments seeking to 
detect differential gene expression, involve calculating a large number of p-values. 
This leads to the multiple testing problem: when the number of null hypotheses is 
large, the probability of accepting at least one false alternative hypothesis is often 
much greater than the significance level of the tests, which tends to mislead investi-
gators. Software called HighProbability provides a simple, fast, reliable solution to 
the multiple testing problem, with applications to many areas of bioinformatics. For 
example, in a microarray study, HighProbability can determine which genes are 
probably differentially expressed. Given a set of p-values not adjusted for multiple 
testing, HighProbability determines which ones are low enough to imply a high 
probability of the truth of their alternative hypotheses. The set of p-values may be 
determined by conventional hypothesis testing or by random permutations using 
existing R or S-PLUS software. HighProbability is freely available under license 
through http://www.davidbickel.com.  Coded in S, HighProbability currently 
requires an installation of R or S-PLUS, but the algorithm is short enough for fast 
implementation in non-S languages as well.
INTRODUCTION
Many problems in bioinformatics  involve testing a large number of null hypotheses.  In
statistical  terminology,  each  null  hypothesis  is  true  if  and  only  if  an  alternative  hypothesis  is
false;  each null  hypothesis  is  a statement  that  there is no effect in the population,  so its  corre-
sponding alternative hypothesis  states that there is an effect in the population.  For example,  in
a two-group  microarray  study, the alternative hypothesis  associated  with a gene may state that
it is differentially  expressed across the two populations  from which the two groups are consid-
ered random samples.  Conventional  hypothesis  testing assigns a p-value to each test such that,
for a given test, the null hypothesis is rejected (considered false) and the alternative hypothesis
is accepted (considered true) only if the p-value is less than or equal to some significance level
a such as a=0.05.  Then,  if the null hypothesis  is true, a  is the probability  of making a Type I
error, i.e., of accepting the false alternative hypothesis. (a is commonly, but completely, misun-
derstood as the probability that the null hypothesis is true.) The multiple testing problem is that
when  m,  the  number  of  hypotheses,  is  large,  the  probability  of  accepting  at  least  one  false
alternative  hypothesis  is  much  greater  than  a,  often  misleading  investigators.  A  powerful,
flexible approach to the multiple testing problem is to find the value of a such that the probabil-
ity  that  an  accepted  alternative  hypothesis  is  true  equals  or  exceeds  some  specified  level  p1 .
This  level  depends  on  the  goals  of  the  investigator:  Efron  et  al.  (2001)  used  p1 = 90 %  to
ensure a high confidence in accepted alternative hypotheses, and Kendziorski et al. (2003) used
p1 = 50 % to determine which alternative hypotheses are more likely than not. The approach of
the  former  relied  on  nonparametric  density  estimation,  whereas  that  of  the  latter  relied  on
parametric modeling, but the value of p1  is not tied to the approach.
It has  been shown that this  problem of determining  which alternative  hypotheses  have
posterior  probabilities  of at least p1  is equivalent  to the problem of deciding which alternative
hypotheses are most advantageously  considered true based on H1 - p1L-1 - 1  as the ratio of the
cost  of  considering  a  false  alternative  true  to  the  benefit  of  considering  a  true  alternative  true
(Bickel 2004b). (Müller et al. (2004) noticed an equivalent  relationship between decision-theo-
retic optimization and using a posterior probability  threshold.)  Unlike other posterior probabil-
ity  threshold  methods,  the  method  of  Bickel  (2004b)  does  not  require  the  estimation  of  any
probability  density.  A nonparametric  form of  the  method  performs  much  better  than  a  related
nonparametric  method  based  on  density  estimation  (Bickel  2004b).  Nonparametric  methods
have  the  advantage  of  obviating  distributional  assumptions  and  extensive  model  validation.
Thus, the decision-theoretic method of determining which alternative hypotheses have probabili-
ties above some threshold (Bickel 2004b) has been implemented as HighProbability  to make it
readily available to the scientific community.
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IMPLEMENTATION & ALGORITHM
The current  implementation  of HighProbability  requires  either of the two S engines,  R
or  S-PLUS.  Each  engine  has  its  advantages;  most  notably,  R  (R  Development  Core  Team,
2003) is freely available  and has convenient  scoping rules, whereas S-PLUS (Insightful  Corp.)
comes  with  a  high-quality  graphical  user  interface  and  telephone  technical  support.  Software
suites  implementing  some  of  the  latest  statistical  methods  for  microarray  analysis  are  the
Bioconductor.org  suite  for  R  and  the  S+ArrayAnalyzer  suite  (Insightful  Corp.)  for  S-PLUS.
However,  these  add-on  suites  are  not  needed  for  HighProbability  since  R  and  S-PLUS  have
many reliable built-in functions for the computation of p-values.
The  main  algorithm  of  HighProbability  is  short  enough  to  be  easily  implemented  in
non-S languages as well:
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Input: 
•   Required: !, a vector of p-values, !1, !2, …, !m  (with one p-value corre-
sponding to each of m hypothesis tests);
•   Optional: p1 , the lowest probability that an alternative hypothesis can have for 
it to be considered true, conditional on the p-value (this is the minimum accept-
able probability of differential expression for a gene to be considered differen-
tially expressed, and is 50% by default);
•   Optional: p1 , the marginal probability that an alternative hypothesis is true. 
(This can be conservatively set to 0, as per Benjamini and Hochberg (1995), 
but the methods of Storey (2003) can yield less conservative estimates of 
p1 = 1 - p0, where p0  is the marginal probability that a null hypothesis is true. 
By default, a recursive call to the algorithm with p1 = 0 and p1 = 50 % is used 
to estimate p1 . This could be repeated until convergence, but a single iteration 
is sufficient for most purposes.)
Output: 
•   I, a vector of indicator (boolean) values, I1, I2, …, Im , corresponding to the 
p-values, where TRUE indicates that the corresponding alternative hypothesis 
has a probability of at least p1 , and FALSE indicates that it does not. That is, 
the jth null hypothesis is rejected and the jth alternative hypothesis is accepted 
if I j = TRUE; otherwise, the jth null hypothesis is not rejected.
Step 1.
Set the levels of significance, denoted by the vector a, equal to the vector of 
p-values, i.e., " jœ81,2,…,m< a j ≠ ! j .  Each level of significance is a p-value threshold 
and a test-wise Type I error rate.
Step 2.
For j = 1, 2, …, m,  at the jth level of significance, compute, Rj ,  the number of 
rejections of the null hypothesis. This is the number of p-values less than or equal to 
the jth significance level: Rj ≠ #kœ81,2,…,m<  !k § a j .
Step 3.
For j = 1, 2, …, m,  estimate the decisive false discovery rate (dFDR) at the jth level 
of significance using the standard estimator:
D
`
j ≠
H1-p1 L aiÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅÅRj êm , Rj > 0
0, Rj = 0
.
Step 4.
For j = 1, 2, …, m,  compute the relative net desirability or relative gain with a j  as 
the significance level (Bickel, 2003): gj ≠ J1 - D` jÅÅÅÅÅÅÅÅÅÅÅÅ1-p1 N Rj .
Step 5.
Compute aoptimal , the significance level at which the relative gain is maximized: 
jHoptimalL ≠ argmax jœ81,2,…,m<  gj ; aoptimal ≠ a jHoptimalL . (Notice that 
gjHoptimalL = max jœ81,2,…,m< gj .)
Step 6.
For j = 1, 2, …, m,  consider the jth alternative hypothesis sufficiently probable if 
and only if it is accepted at significance level aoptimal  and g jHoptimalL > 0:
 
I j ≠
TRUE, ! j § aoptimal and gjHoptimalL > 0
FALSE, ! j > aoptimal or gjHoptimalL § 0 .
For readers more familiar  with S than with mathematical  notation,  the algorithm may be better
understood  by  an  examination  of  the  HighProbability  function  alternative.probable,  which
prints on less than two pages. The source code also specifies the details of handling errors, ties,
and special situations.
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DEMONSTRATION
The  main  function  of  HighProbability  is  alternative.probable,  illustrated  here.  The
function  alternative.beneficial  does  the  same  thing,  except  that  in  replacing  the  p1  argu-
ment with a cost-to-benefit  ratio argument,  it implements  Bickel (2003). Although  HighProba-
bility  applies  to  general  multiple  testing  problems,  the  special  terminology  of  differential
expression  will  make  an  important  application  to  microarrays  clear.  Consider  10  simulated
microarrays,  each  with  expression  levels  of  1000  genes  of  interest.  The  logarithms  of  the
expression levels (LELs) were independently and randomly generated from the normal distribu-
tion with zero mean and unit variance, except for those of the first 100 genes of the five microar-
rays  constituting  the  first  group,  which  were  generated  from  the  normal  distribution  with  a
mean of two and a variance  of one. Thus,  only the first  100 genes  are differentially  expressed
between that group and the remaining five microarrays, which constitute  the second group. As
if  that  were  not  known,  a  p-value  was  computed  for  each  of  the  1000  genes  using  the  two-
sided,  equal-variance  t-test.  (Various  t-tests,  Wilcoxon  rank-sum  tests,  and  nonparametric
permutation tests are easily performed using the t.test, wilcox.test,  and sample functions of
S,  respectively.  The  wilcox.test  function  facilitated  nonparametrically  testing  more  biologi-
cally relevant  null  hypotheses  (Bickel  2004a).)  These  1000  p-values  were  stored in the vector
p.values, the actual argument of alternative.probable:
> ap.50 <- alternative.probable(p.values)
Using marginal.probability estimate of  0.088
Here,  p1 = 50 %,  as  no  value  was  specified  for  the  formal  argument  min.probability.  Like-
wise, since the argument marginal.probability, corresponding to p1 , was not be specified, p1
was  estimated  by  initially  using  the  most  conservative  value,  marginal.probability  = 0.  As
desired, the estimate,  8.8%, is close to but no greater than the actual value,  10%, which would
be unknown.  The values of the  indicator vector I  are stored in ap.50.  HighProbability  discov-
ered  60  of  the  100  differentially  expressed  genes  and  falsely  discovered  only  28  of  the  900
equivalently expressed genes:
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equivalently expressed genes:
> sum(ap.50[1:100])
[1] 60
> sum(ap.50[101:1000])
[1] 28
To reduce the number of false discoveries, but also the number of true discoveries, the investiga-
tor can use p1 = 90 %:
> ap.90 <- alternative.probable(p.values, min.probability = 0.90)
Using marginal.probability estimate of  0.088 
> sum(ap.90[1:100])
[1] 13
> sum(ap.90[101:1000])
[1] 2
In this case, the results are not affected by using 0% rather than 8.8% as the value of p1 :
> ap.conservative.90 <- alternative.probable(p.values, min.probability = 0.90, 
marginal.probability = 0)
> sum(ap.conservative.90[1:100])
[1] 13
> sum(ap.conservative.90[101:1000])
[1] 2
As  time  and  computation  power  allow,  investigators  may  perform  exploratory  analysis  with
HighProbability by varying p1  from 50% to 95% in increments of 5%. Finer increments can be
used to estimate the probability  of differential  expression  for each gene (Bickel 2004b). When
set to TRUE, the additional argument plot.relative.gain produces a plot of gj  versus a j :
> ap.50 <- alternative.probable(p.values, plot.relative.gain = TRUE)
aoptimal  is the value of the horizontal axis at which gj  reaches its maximum. 
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